Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease

International Urology and Nephrology

Volumn 40, Issue 4, 2008, Pages 1083-1087

  Ahmad, Mufazzal ^a,b   Robert, Richardson ^a   Bargman, Joanne M ^a   Oreopoulos, Dimitrios ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b NONE   (Canada)

Author keywords

Cardiac allograft recipients; Chronic kidney disease; Congestive heart failure; End stage renal disease; Fluid overload; Heart transplantation; Hemodialysis; Hospitalization; Kidney failure; Peritoneal dialysis; Renal replacement therapy

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN DERIVATIVE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL PERITONITIS; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONGESTIVE HEART FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTINUOUS CYCLER PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE URINE LEVEL; DIALYSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT RECIPIENT; HEART FUNCTION TEST; HEART TRANSPLANTATION; HEMODIALYSIS; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; NEPHROTOXICITY; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

CHI-SQUARE DISTRIBUTION; FEMALE; HEART TRANSPLANTATION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 56249091732     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9406-z     Document Type: Article

References (8)

1. Van de Wetering J, Weimar CH, Balk AH, Roodnat JI, Holweg CT, Baan CC, van Domburg RT, Weimar W (2006) The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation. Transplantation 82:1744-1748
2. Alam A, Badovinac K, Ivis F, Trpeski L, Cantarovich M (2007) The outcome of heart transplant recipients following the development of end-stage renal disease: Analysis of the Canadian Organ Replacement Register (CORR). Am J Transplant 7:461-465
3. Yang X, Fang W, Kothari J, Khandelwal M, Naimark D, Jassal SV, Bargman JM, Oreopoulos DG (2007) Clinical outcomes of elderly patients undergoing chronic peritoneal dialysis: Experiences from one center and a review of the literature. Int Urol Nephrol 39:1295-1302
4. Giannattasio M, Buemi M, Caputo F, Viglino G (2003) Can peritoneal dialysis be used as a long term therapy for end stage renal disease? Int Urol Nephrol 35:569-577
5. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931-940
6. Pattison JM, Petersen J, Kuo P, Valantine V, Robbins R, Theodore J (1995) The incidence of renal failure in one hundred consecutive heart-lung recipients. Am J Kidney Dis 26:643-648
7. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D (1997) Cyclosporine-associated end-stage nephropathy after cardiac transplantation: Incidence and progression. Transplantation 63:664-668
8. Jayasena SD, Riaz A, Lewis CM, Neild GH, Thompson FD, Woolfson RG (2001) Outcome in patients with end-stage renal disease following heart or heart-lung transplantation receiving peritoneal dialysis. Nephrol Dial Transplant 16:1681-1685